SCHEMBL4055895

SCHEMBL4055895

[CH2]Cc1cccc(C(C)N(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ACHE P22303 16/20 0.44
BCHE P06276 15/20 0.44
FAAH O00519 1/20 0.43
MARK4 Q96L34 1/20 0.38
ASIC3 Q9UHC3 1/20 0.36
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063234 1.00 ACHE (0.44) ACHEBCHEFAAHMARK4ASIC3
SCHEMBL2921664 0.80 HDAC4 (0.42) BCHEMAPT
SCHEMBL5022783 0.79 ACHE (0.46) ACHEBCHEFAAHMAPT
SCHEMBL21802665 0.77 MEN1 (0.47) MEN1KMT2A
SCHEMBL21802668 0.77 MEN1 (0.47) MEN1KMT2A
SCHEMBL28874730 0.77 TAAR1 (0.42)
SCHEMBL17801461 0.76 DAO (0.45)
SCHEMBL7855054 0.74 PTGS2 (0.33)
SCHEMBL24222513 0.74 ACHE (0.50) ACHEBCHEFAAHMARK4MEN1
SCHEMBL19724322 0.72 ACHE (0.49) ACHEBCHEFAAHMARK4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2109600-A2 AMORPHOUS AND CRYSTALLINE FORMS OF RIVASTIGMINE HYDROGENTARTRATE Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2009-10-21 EP disclosed
WO-2008081041-A2 AMORPHOUS AND CRYSTALLINE FORMS OF RIVASTIGMINE HYDROGENTARTRATE KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) 2008-07-10 WO disclosed